New chemo combo shows promise against tough pancreatic cancer
NCT ID NCT03443492
First seen Jan 05, 2026 · Last updated Apr 23, 2026 · Updated 15 times
Summary
This study tested two different chemotherapy combinations—SLOG and mFOLFIRINOX—as the first treatment for people with advanced pancreatic cancer that cannot be removed by surgery or has spread. A total of 130 participants were enrolled to see which combination worked better at controlling the cancer for longer. The goal was to improve progression-free survival, meaning how long patients lived without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institute of Cancer Research
Miaoli, Taiwan
Conditions
Explore the condition pages connected to this study.